Om. Kew et al., PROLONGED REPLICATION OF A TYPE-1 VACCINE-DERIVED POLIOVIRUS IN AN IMMUNODEFICIENT PATIENT, Journal of clinical microbiology, 36(10), 1998, pp. 2893-2899
VP1 sequences were determined for poliovirus type 1 isolates obtained
over a 189-day period from a poliomyelitis patient with common variabl
e immunodeficiency syndrome (a defect in antibody formation), The isol
ate from the first sample, taken 11 days after onset of paralysis, con
tained two poliovirus populations, differing from the Sabin 1 vaccine
strain by similar to 10%, differing from diverse type 1 wild polioviru
ses by 19 to 24%, and differing from each other by 5.5% of nucleotides
. Specimens taken after day Il appeared to contain only one major poli
ovirus population. Evolution of YP1 sequences at synonymous third-codo
n positions occurred at an overall rate of similar to 3.4% per year ov
er the 189-day period. Assuming this rate to be constant throughout th
e period of infection, the infection was calculated to have started si
milar to 9.3 years earlier. This estimate is about the time (6.9 years
earlier) the patient received his last oral poliovirus vaccine dose,
approximately 2 years before the diagnosis of immunodeficiency, These
findings may have important implications for the strategy to eliminate
poliovirus immunization after global polio eradication.